Wound News and Research

RSS

NSAIDs like ibuprofen slow the spread of breast cancers

Published online on Aug. 7, 2011, the journal Nature Medicine reports that non-steroidal anti-inflammatory drugs including ibuprofen reduce the severity of postpartum breast cancers in animal models.

12 Aug 2011

Researchers develop epidermal electronic system

Through a combination of careful theoretical modeling and precise micro-manufacturing, a team of engineers and scientists has developed a new type of ultra-thin, self-adhesive electronics device that can effectively measure data about the human heart, brain waves and muscle activity - all without the use of bulky equipment, conductive fluids, or glues.

12 Aug 2011

SANUWAVE second quarter revenues increase 40%

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today reported financial results for the three and six months ended June 30, 2011 and provided a business update.

10 Aug 2011

Covalon to showcase latest line of innovative wound care and coating products at FIME Expo

Covalon Technologies Ltd., an advanced medical technologies company, today announced it is presenting its latest line of advanced wound care and medical coating products, including ColActive® Plus Ag from August 10th to 12th at FIME International Medical Expo.

8 Aug 2011

Study: miR-200s play a paradoxical role in metastatic cancer development

While they may be small in size, a family of tiny molecules called microRNAs could potentially play a large role in the process of cancer metastasis, or the spread of cancer from one area of the body to another.

8 Aug 2011

Osiris second quarter revenues increase to $10.4 million

Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory and cardiovascular disease areas and wound healing, announced today its results for the second quarter ended June 30, 2011.

5 Aug 2011

Dermatologist discusses common skin conditions that affect people of color at AAD 2011 meeting

The U.S. Census Bureau predicts that by the year 2050, more than half the U.S. population will have skin of color. Recognizing this trend, dermatologists are educating the public about the different ways that common skin conditions appear in various skin tones.

5 Aug 2011

Key protein discoveries could lead to new lung repair therapies for children, adults

A team at The Saban Research Institute of Children's Hospital Los Angeles has made crucial discoveries about the role of key proteins in wound healing in the tiny air sacs in the lungs known as "alveoli" that could lead to new therapies for children and adults.

5 Aug 2011

SWHR congressional briefing highlights health issues facing women veterans today

The physical and mental health problems affecting women veterans are a major issue within the Department of Veterans Affairs (VA) and the Department of Defense, and the catalyst for the Society for Women's Health Research (SWHR) congressional briefing, Women Veteran's Health: Sexx Matters held on Tuesday, August 2.

4 Aug 2011

New investment to strengthen Clearbridge Accelerator's incubation platform

Clearbridge Accelerator announced today that it has received an investment from Tim Draper, a well-established venture capitalist based in the Silicon Valley.

2 Aug 2011

FDA clears Derma Sciences' MEDIHONEY Hydrogel Wound and Burn Dressing

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced it has received U.S. Food and Drug Administration 510(k) clearance for its patented MEDIHONEY Hydrogel Wound and Burn Dressing with Leptospermum honey.

2 Aug 2011

'Systems biology' study of breast cancer

Using a "systems biology" approach - which focuses on understanding the complex relationships between biological systems - to look under the hood of an aggressive form of breast cancer, researchers for the first time have identified a set of proteins in the blood that change in abundance long before the cancer is clinically detectable.

29 Jul 2011

RegeneRx to initiate enrollment in RGN-259 Phase 2 trial for dry eye syndrome

RegeneRx Biopharmaceuticals, Inc. has announced that it is set to begin a Phase 2 clinical trial in 72 patients with dry eye syndrome.

29 Jul 2011

TMS rolls out MUNI for law enforcement and other government agencies

Total Medical Solutions (TMS), specializing in complex care for workers' compensation, has rolled out MUNI for municipalities, law enforcement and other government agencies.

27 Jul 2011

Cocaine-free topical anaesthetics can effectively treat pain caused by torn skin

While some pain killers need to be injected into the damaged tissue in order to work, topical anaesthetics only need to be spread on the surface. The earliest examples of "topical" anaesthetics contained cocaine, but now a new systematic review has shown that newer agents that don't contain cocaine can effectively treat pain caused by torn skin.

27 Jul 2011

Kinetic Concepts second quarter total revenue increases 4% to $519.8 million

Kinetic Concepts, Inc. today reported second quarter 2011 total revenue of $519.8 million, an increase of 4% from the second quarter of 2010.

26 Jul 2011

MiMedx second quarter revenue increases 85% to $1,929,000

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the second quarter and six months ended June 30, 2011.

25 Jul 2011

Experts to explore wound healing abilities of dolphins

A Georgetown University Medical Center (GUMC) scientist who has previously discovered antimicrobial compounds in the skin of frogs and in the dogfish shark has now turned his attention to the remarkable wound healing abilities of dolphins.

21 Jul 2011

Alliqua acquires global license for wound care dressings from Noble Biomaterials

Alliqua, Inc., an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and wound care technologies today announced that it has acquired from Noble Biomaterials, Inc. a 10 year exclusive global license for two wound care dressings, with an additional 10 year renewal option.

21 Jul 2011

U.S. News ranks University of Texas MD Anderson as leading hospital for cancer care

For the fifth straight year, The University of Texas MD Anderson Cancer Center is the leading hospital in the nation for cancer care, according to the "Best Hospitals" survey published annually by U.S. News & World Report magazine.

21 Jul 2011

Wound News and Research

NSAIDs like ibuprofen slow the spread of breast cancers

Researchers develop epidermal electronic system

SANUWAVE second quarter revenues increase 40%

Covalon to showcase latest line of innovative wound care and coating products at FIME Expo

Study: miR-200s play a paradoxical role in metastatic cancer development

Osiris second quarter revenues increase to $10.4 million

Dermatologist discusses common skin conditions that affect people of color at AAD 2011 meeting

Key protein discoveries could lead to new lung repair therapies for children, adults

SWHR congressional briefing highlights health issues facing women veterans today

New investment to strengthen Clearbridge Accelerator's incubation platform

FDA clears Derma Sciences' MEDIHONEY Hydrogel Wound and Burn Dressing

'Systems biology' study of breast cancer

RegeneRx to initiate enrollment in RGN-259 Phase 2 trial for dry eye syndrome

TMS rolls out MUNI for law enforcement and other government agencies

Cocaine-free topical anaesthetics can effectively treat pain caused by torn skin

Kinetic Concepts second quarter total revenue increases 4% to $519.8 million

MiMedx second quarter revenue increases 85% to $1,929,000

Experts to explore wound healing abilities of dolphins

Alliqua acquires global license for wound care dressings from Noble Biomaterials

U.S. News ranks University of Texas MD Anderson as leading hospital for cancer care

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News